Outcome analysis in patients with uterine sarcoma - Wikidata - awgldk - TriplyDB

Outcome analysis in patients with uterine sarcoma

Outcome analysis in patients with uterine sarcoma

http://www.wikidata.org/entity/Q35375270

about

Clinical outcomes of tissue expanders on adjuvant radiotherapy of resected retroperitoneal sarcoma.Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).Review of Recommended Treatment of Uterine Carcinosarcoma.

P2860

Q37116792-9112F258-9C2E-40BA-B11A-0C99246B2460 Q37364032-C3C85E62-D522-4F04-9DD5-859C79497FAC Q38587635-539921AE-A57C-46B5-98D0-C06344DFF1D1

P2860

Outcome analysis in patients with uterine sarcoma

http://www.wikidata.org/entity/Q35375270

description

2015 nî lūn-bûn

@nan

2015 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի մարտին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Outcome analysis in patients with uterine sarcoma

@ast

Outcome analysis in patients with uterine sarcoma

@en

type

label

Outcome analysis in patients with uterine sarcoma

@ast

Outcome analysis in patients with uterine sarcoma

@en

prefLabel

Outcome analysis in patients with uterine sarcoma

@ast

Outcome analysis in patients with uterine sarcoma

@en

P1433

Q35375270-9436F5EB-4C19-4DCC-9520-7AD52BDB1B07

P1476

Q35375270-15A46D05-C4C1-4F90-A558-062B7AD78D7A

P2093

Q35375270-1EABFCB1-4D6A-492D-8C13-C6EC07C40183

Q35375270-29960A4E-1EFE-42DA-A381-8E5B0D3E8A67

Q35375270-2A0FAE82-1D75-4202-926F-3854967A1B8E

Q35375270-2D83564C-654C-4690-ABD9-727ED5DB8894

Q35375270-8F13FE51-3F6B-4DFC-8DB9-971E229CBE69

Q35375270-9CE32148-13F3-4E39-A2E2-E980E59FF5F7

Q35375270-BE984BF0-3B81-44CB-AEAD-313D6181E2E8

P2860

Q35375270-0145381D-6F5F-4496-9C38-90C5FE01FFE2

Q35375270-0954D875-B122-48C0-8498-851F83BC933C

Q35375270-16C3F6F6-0A8B-4C9C-B903-0499079FD053

Q35375270-1D722334-9883-4968-8F99-F6C0DFC5747C

Q35375270-2E8FAFE3-D2B0-4D43-8568-DD2B17A1B14C

Q35375270-33572F46-4B69-4150-97D0-B1E34FF7D8BE

Q35375270-345B986B-1A05-48C6-9D25-DB4D0504F176

Q35375270-4342E8F5-985A-408E-9695-D44CB1F296DA

Q35375270-4CEB4698-494D-410B-AB0E-0F79AB901AEB

Q35375270-50714F89-B9D1-4010-84A1-C97293B10F26

P304

Q35375270-B6F6184E-8A10-4013-9759-0D87DB0628BE

P31

Q35375270-93452B85-82C7-4FD2-A4DF-FFFBAD51F605

P356

Q35375270-0941E25D-9001-465C-8D23-6A5924627A2A

P433

Q35375270-38E9682F-730E-46FB-A822-11BFC31B224C

P478

Q35375270-0054857A-A6B6-48A6-9402-BB26AB258106

P577

Q35375270-65508FBF-EB23-4608-A4F5-5BF0FA8B270F

P5875

Q35375270-9D91BB74-DFDF-4F6A-AE4A-157AA541D1FC

P698

Q35375270-F24A7682-D677-4ED5-B0B1-BA4FD4A164C8

P932

Q35375270-925B29A5-3059-47F1-A85C-332DCD328B74

P356

ROJ.2015.33.1.29

P1433

Radiation oncology journal

P1476

Outcome analysis in patients with uterine sarcoma

@en

P2093

Hak Jae Kim

http://www.w3.org/2001/XMLSchema#string

Hong-Gyun Wu

http://www.w3.org/2001/XMLSchema#string

Jae-Won Kim

http://www.w3.org/2001/XMLSchema#string

Noh-Hyun Park

http://www.w3.org/2001/XMLSchema#string

Sung Whan Ha

http://www.w3.org/2001/XMLSchema#string

Tosol Yu

http://www.w3.org/2001/XMLSchema#string

Yong-Sang Song

http://www.w3.org/2001/XMLSchema#string

P2860

A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage I-IV carcinosarcoma (CS) of the uterus.

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.

Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas.

The influence of adjuvant radiotherapy on patterns of failure and survivals in uterine carcinosarcoma.

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients.

Role of radiotherapy treatment of uterine sarcoma.

Leiomyosarcoma of the uterus: A clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 49 cases.

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

Treatment, results and prognostic factors in stage I and II sarcomas of the corpus uteri.

P304

29-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3857/ROJ.2015.33.1.29

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275046804

http://www.w3.org/2001/XMLSchema#string

P698

25874175

http://www.w3.org/2001/XMLSchema#string

P932

4394066

http://www.w3.org/2001/XMLSchema#string